Skip to main content


🦠
"As of 2 December 2022, over 82,000 human #mpox (or #monkeypox) cases have been laboratory confirmed in 110 countries worldwide."

And sporadic reports are still coming in:
https://c.im/@andrew_a_lover/109673550181706348

This may be what a very very very slow pandemic looks like.
🦠
As a step towards the development of an #antiviral, (Peng et al., 2022) recently elucidated the structure of the mpox DNA polymerase:

"Structure of monkeypox #virus DNA polymerase holoenzyme"
https://doi.org/10.1126/science.ade6360
#virology @virology
This entry was edited (1 year ago)
Unknown parent

Eric Pyrrhus
1/6
🦠 A Few More #Mpox ( #MonkeyPox) Pandemic Updates 🦠

"Assuming APOBEC-editing is characteristic of [mpox] infection in human hosts, we propose an APOBEC clock that – at a rate of ~6 APOBEC3 mutations per year – estimates [mpox] has been circulating in humans since 2016."
https://www.biorxiv.org/content/10.1101/2023.01.23.525187v1

#virus #virology @virology #epidemiology #InfectiousDisease
This entry was edited (1 year ago)
in reply to Eric Pyrrhus

2/6
"The smallpox and mpox #vaccine (MVA-BN), provided as a two-dose regimen, is currently the primary vaccine utilized against mpox...
We evaluated the real-world effectiveness of a single, subcutaneous dose of MVA-BN in this observational, retrospective cohort study...
The adjusted vaccine effectiveness was estimated at 86%."
https://www.nature.com/articles/s41591-023-02229-3
This entry was edited (1 year ago)
in reply to Eric Pyrrhus

3/6
The use of the only broad-spectrum #antivirals designed for DNA virus infections (brincidofovir & cidofovir) may be under-utilized for Mpox infections:

"A 48-year-old man with poorly controlled HIV presented with severe [mpox] infection, having completed 2 weeks of tecovirimat...
Despite a second, prolonged course of tecovirimat, he did not improve...
Intravenous cidofovir was given at 5 mg/kg; the patient made a noticeable improvement after the first IV dose..."
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00044-0
This entry was edited (1 year ago)
in reply to Eric Pyrrhus

4/6
More discussion of how the use of the only broad-spectrum #antivirals designed for DNA virus infections (brincidofovir & cidofovir) may be under-utilized for Mpox infections:

"Oral Brincidofovir Therapy for Monkeypox Outbreak: A Focused Review on the Therapeutic Potential, Clinical Studies, Patent Literature, and Prospects"
https://www.mdpi.com/2227-9059/11/2/278
This entry was edited (1 year ago)
in reply to Eric Pyrrhus

5/6
A first attempt at describing the post-acute effects of Mpox infection:

"The later consequences of the disease remain unknown. We, therefore, aimed to evaluate the medium- and long-term morbidity following the acute episode of mpox."
https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2023.28.7.2300072
in reply to Eric Pyrrhus

6/6
Besides the large impact of the Mpox pandemic on Latin America, reports continue to come in from East Asia:

Taiwan reports two locally acquired Mpox infections:
https://outbreaknewstoday.com/taiwan-reports-2-local-monkeypox-cases-in-hsinchu-county-and-kaohsiung-city-28588/

Mpox acquired by a health care worker in South Korea via needle-stick injury:
https://wwwnc.cdc.gov/eid/article/29/5/23-0028_article
in reply to Eric Pyrrhus

7/6
Interesting report on #Mpox #virus:
(AKA #MonkeyPox or #MPXV)

"We monitored SARS-CoV-2 & MPXV genomes in the air... in Madrid nightclubs... in 2022.
...
MPXV in the air had increased considerably on Aug 8, with 57% of positive samples containing more than 100 genomes per [cubic meter]; this date coincided with the peak incidence of mpox in Spain."

The authors suggest that air sampling might be a useful surveillance method.

#virology #epidemiology #InfectiousDisease
https://doi.org/10.1016/S2666-5247(23)00104-0

Lo, thar be cookies on this site to keep track of your login. By clicking 'okay', you are CONSENTING to this.